https://www.tudca.eu/https://www.tudca.eu/?s={search_term_string}https://www.tudca.eu/about/https://www.tudca.eu/author/chantalj/https://www.tudca.eu/author/charlotter/https://www.tudca.eu/author/mnd_admin/https://www.tudca.eu/author/sophien/https://www.tudca.eu/final-participant-randomised-to-the-tudca-als-trial/https://www.tudca.eu/login/https://www.tudca.eu/members/https://www.tudca.eu/news-events-media-comment-on-the-results-of-the-centaur-trial/https://www.tudca.eu/news-events-media/https://www.tudca.eu/news-events-media/?_sft_post_tag=tudca-als-meetinghttps://www.tudca.eu/news-events-media/?sf_paged=2https://www.tudca.eu/newsletter/https://www.tudca.eu/newsletter/thank-you-for-signing-up/https://www.tudca.eu/presentations/https://www.tudca.eu/privacy/https://www.tudca.eu/search/%7Bsearch_term_string%7D/https://www.tudca.eu/take-part/https://www.tudca.eu/terms/https://www.tudca.eu/top-line-results-announcement/https://www.tudca.eu/tudca-als-a-trial-to-investigate-tudca-as-an-add-on-treatment-for-als-has-reached-the-halfway-point-in-its-recruitment/https://www.tudca.eu/tudca-als-end-of-double-blind-phase-iii-trial/https://www.tudca.eu/tudca-als-kick-off-meeting-milan-september/https://www.tudca.eu/tudca-als-project-begins/https://www.tudca.eu/tudca-als-recruits-first-participant/https://www.tudca.eu/tudca-als-study-continues-despite-covid-19-outbreak/https://www.tudca.eu/tudca-als-trial-protocol-published/https://www.tudca.eu/tudca-als-website-goes-live-1st-june-2018/